G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2004
10/28/2004	WO2004083370A3 Method of detecting and analysing organelles immobilised on biochips and applications thereof
10/28/2004	WO2004081579A3 Protocol for monitoring platelet inhibition
10/28/2004	WO2004081531A9 Ligand analysis
10/28/2004	WO2004076679A3 Serum macrophage migration inhibitory factor (mif) as marker for prostate cancer
10/28/2004	WO2004075713A3 Multiple marker assay for detection of ovarian cancer
10/28/2004	WO2004072651A3 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine 1f receptor (5-ht1f)
10/28/2004	WO2004072645A3 Identification of organic compounds capable of modulating the activity of epithelial sodium ion channels
10/28/2004	WO2004072643A3 Diagnostics and therapeutics for diseases associated with glucagon-like peptide 2 receptor (glp2r)
10/28/2004	WO2004071396A3 Diagnostics and therapeutics for diseases associated with parathyroid hormone receptor 2 (pthr2)
10/28/2004	WO2004067023A3 Survivin-derived peptides and use thereof
10/28/2004	WO2004061456A3 Uses of hmgb, hmgn, hmga proteins
10/28/2004	WO2004060832A3 Fluorescent creatinine assay
10/28/2004	WO2004060145A3 Isolation and identification of cross-reactive t cells
10/28/2004	WO2004059277A3 Methods of collecting and transporting vaginal discharge for detection of infectious organisms and to facilitate cervical cancer screening
10/28/2004	WO2004058292A3 Methods and compositions for suppressing fibrocyte differentiation
10/28/2004	WO2004056857A3 Use of the multifunctional transcription factor yin-yang-1 and variants thereof for treating illnesses, especially type 1 diabetes
10/28/2004	WO2004053454A3 Methods for detecting invasion of a cell
10/28/2004	WO2004053057A3 Gene expression systems and recombinant cell lines
10/28/2004	WO2004048967A3 Analytical method and apparatus
10/28/2004	WO2004046339A3 Caged sensors, regulators and compounds and uses thereof
10/28/2004	WO2004043386A3 Molecules preferentially associated with effector t cells and methods of their use
10/28/2004	WO2004041996A3 System for and method of positioning cells and determining cellular activity thereof
10/28/2004	WO2004041857A3 Mutant of clostridium difficile toxin b and methods of use
10/28/2004	WO2004032867A3 Molecules preferentially associated with effector t cells or regulatory t cells and methods of their use
10/28/2004	WO2004025223A3 Method for monitoring sensor function
10/28/2004	WO2004024075A3 Chemokine receptor antagonists as therapeutic agents
10/28/2004	WO2004018709A3 Single nucleotide polymorphisms predicting adverse drug reactions and drug efficacy in cardiovascular disease
10/28/2004	WO2004016746A3 Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing a c-myc protein
10/28/2004	WO2004016148A3 Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3 expressing tumors
10/28/2004	WO2004013633A3 Method for isolating atp binding proteins by means of immobolized protein inhibitors
10/28/2004	WO2004009777A3 Compositions and methods to select dendritic cells from a heterogeneous cell population
10/28/2004	WO2004005477A3 Protein microarrays on mirrored surfaces for performing proteomic analyses
10/28/2004	WO2004005319A3 Microarrays on mirrored substrates for performing proteomic analyses
10/28/2004	WO2004003176A3 Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs
10/28/2004	WO2004000228A3 Methods for preventing and treating microbial infections by modulating transcription factors
10/28/2004	WO2003104415A3 Method to screen ligands using eukaryotic cell display
10/28/2004	WO2003099229A3 Functional protein expression for rapid cell-free phenotyping
10/28/2004	WO2003089573A3 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof
10/28/2004	WO2003087771A3 Method for making a molecularly smooth surface
10/28/2004	WO2003087764A3 Connection of cells to substrates using association pairs
10/28/2004	WO2003082317A9 Peptide epitopes recognized by antigen specific cd8+ t lymphocytes
10/28/2004	WO2003074007A3 Modulators of leukocyte activation, compositions, and methods of use
10/28/2004	WO2003072600A8 Methods of screening molecular libraries for active molecules that restore the function of target proteins and peptides that restore the function of mutant p53
10/28/2004	WO2003069335A8 Device and method for determining parameters
10/28/2004	WO2003057850A3 Binding proteins as biosensors
10/28/2004	WO2003041635A3 Methods and compositions for therapeutic treatment of cathepsin k complex-mediated disorders
10/28/2004	WO2003040347A3 Baalc expression as a diagnostic marker for acute leukemia
10/28/2004	WO2003030833A3 Angiopoietin-2 specific binding agents
10/28/2004	WO2003022882A3 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle
10/28/2004	WO2003020954A3 205p1b5 in treatment and detection of cancer
10/28/2004	WO2002088322A3 Cell adhesion and extracellular matrix proteins
10/28/2004	WO2002055189A3 Nanoporous membrane reactor for miniaturized reactions and enhanced reaction kinetics
10/28/2004	US20040216177 Congenic rats containing a mutant GPR10 gene
10/28/2004	US20040216176 Compositions and methods for characterizing and regulating Wnt pathways
10/28/2004	US20040215516 Locations based promotions
10/28/2004	US20040215403 Method of prediction of in-vivo polymer performance by external experimentation
10/28/2004	US20040215402 Measuring and analyzing multi-dimensional sensory information for identification purposes
10/28/2004	US20040215400 Computational design of a water-soluble analog of a protein, such as phospholamban and potassium channel KcsA
10/28/2004	US20040215398 Method and a system for automating the execution of AMoRe over a heterogenous network of computers
10/28/2004	US20040215134 Optical detector for enzyme activation
10/28/2004	US20040215087 Compositions and methods for the detection of biomarkers associated with cardiovascular disease
10/28/2004	US20040215031 Functionalized silicon compounds and methods for their synthesis and use
10/28/2004	US20040214999 Novel compounds for chemiluminescense procedures
10/28/2004	US20040214995 Melanoma antigens and their use in diagnostic and therapeutic methods
10/28/2004	US20040214992 Mutation induced optimization of receptor signal to noise ratio
10/28/2004	US20040214990 Transmembrane protein differentially expressed in cancer
10/28/2004	US20040214926 A polymeric material void of endocrine disruptive chemicals comprising a monomer(ethylene or propylene) wherein monomer is processed without additon of other additive to form polyethylene or polypropylene; use in baby bottles, baby toys
10/28/2004	US20040214819 Modified amino acids, pharmaceuticals containing these compounds and method for their production
10/28/2004	US20040214766 administering vascular endothelial growth factors to promote cell proliferation and differentiation of neurons and prophylaxis of nervous system disorders
10/28/2004	US20040214765 Methods and means for inhibition of CDK4 activity
10/28/2004	US20040214763 Method for determining the ability of a compound to modify the interaction between parkin and the p38 protein
10/28/2004	US20040214762 administering serine protease inhibitors and optionally in combination with substance P or peptide hormones, for prophylaxis of nervous system disorders, autoimmune disorders and tissue regeneration processes, such as wound healing
10/28/2004	US20040214759 Compositions and methods of use for a fibroblast growth factor
10/28/2004	US20040214757 nuclear proteins which binds, in a sequence specific manner, to regulatory sequences of immunoglobulin light or heavy chain genes; bioassay
10/28/2004	US20040214347 Accessible assay and method of use
10/28/2004	US20040214346 Kit comprising immobilized aggrecanase for use in the diagnosis of thromboembolic disorders
10/28/2004	US20040214345 Double sided membrane for screening blood glucose levels
10/28/2004	US20040214342 Photoluminescent semiconductor materials
10/28/2004	US20040214341 Analytical method for the detection and quantitation of fuel additives
10/28/2004	US20040214339 DIAGNOSTIC ASSAY OF AQUEOUS TEST FLUID (URINE) COMBINED WITH A BUFFER (CITRULLINE) AND DYE AT LOW PH; proteomics
10/28/2004	US20040214338 Using immobilized antibodies to isolate differentially labeled peptides and proteins; proteomics
10/28/2004	US20040214337 Apparatus for accurate measurement of bloods ability to coagulate/lyse; for use in prognosing surgical and medical procedures; diagnosing clotting disorders
10/28/2004	US20040214331 Transforming and propagating viral-like particle in cells; for use as tools in prevention and treatment of viral infection; viricides and genetic vaccines
10/28/2004	US20040214321 Agent for inducing conversion of intestinal cells into insulin-producing cells and antidiabetic drug
10/28/2004	US20040214319 Using lysophospholipid G-protein coupled receptor (LPL) to initiate spontaneous differentiation of progenitor cells; for use in functional genomics, growth factor and drug discovery, toxicology and cell transplantation
10/28/2004	US20040214312 Biochip apparatus comprising thin film for use in monitoring electrical potential of multiple cells concurrently; high throughput assay drug screens
10/28/2004	US20040214302 Detection of nucleic acids by type-specific hybrid capture method
10/28/2004	US20040214286 Comprises nucleotide sequences coding cell growth factors for use in developing modulators for treatment of cell proliferative, arthritic, skin and vision defects; immunotherapy
10/28/2004	US20040214283 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof
10/28/2004	US20040214279 Insect monoamine transporter and methods of use thereof
10/28/2004	US20040214277 Methods and compositions for polypeptide engineering
10/28/2004	US20040214270 Isocitrate dehydrogenase, gene thereof, and use of the same in the treatment of obesity, hyperlipidemia, and fattly liver in lipid biosynthesis
10/28/2004	US20040214269 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/28/2004	US20040214268 Comprises nucleotide sequences coding membrane proteins for stimulating release of tumor necrosis factor and/or cell proliferation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/28/2004	US20040214267 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/28/2004	US20040214266 Secreted and transmembrane polypeptides nucleic acids encoding the same
10/28/2004	US20040214265 Comprises nucleotide sequences coding membrane proteins for stimulating release of tumor necrosis factor and/or cell proliferation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/28/2004	US20040214264 Comprises nucleotide sequences coding dimethylarginine dimethylaminohydrolase-1 protein (DDAH1) for use in identifying modulators for treatment of diabetes and cardiovascular disorders
10/28/2004	US20040214258 Covalent tethering of functional groups to proteins
10/28/2004	US20040214254 Multizonal immunoassy apparatus for use as diagnostic and prognostic tools in detection of urogenital cell proliferative disorders

1 ... 2244 2245 2246 2247 2248 2249 2250 2251 2252 2253 2254 2255 2256 2257 2258 2259 2260 2261 2262 2263 2264 ... 3937